PMID- 24582917 OWN - NLM STAT- MEDLINE DCOM- 20140609 LR - 20151119 IS - 1090-2430 (Electronic) IS - 0014-4886 (Linking) VI - 255 DP - 2014 May TI - Brain-derived neurotrophic factor in the amygdala mediates susceptibility to fear conditioning. PG - 19-29 LID - S0014-4886(14)00061-2 [pii] LID - 10.1016/j.expneurol.2014.02.016 [doi] AB - Fear conditioning in animals has been used extensively to model clinical anxiety disorders. While individual animals exhibit marked differences in their propensity to undergo fear conditioning, the physiologically relevant mediators have not yet been fully characterized. Here, we demonstrate that C57BL/6 inbred mouse strain subjected to a regimen of chronic social defeat stress (CSDS) can be separated into susceptible and resistant subpopulations that display different levels of fear responses in an auditory fear conditioning paradigm. Susceptible mice had significantly more c-Fos protein expression in neurons of the basolateral amygdala (BLA) following CSDS and showed exaggerated conditioned fear responses, while there were no significant differences between groups in innate anxiety- and depressive-like behaviors. Through the use of conditional brain-derived neurotrophic factor (BDNF) knockout strategies, we find that elevated BLA BDNF level following fear conditioning training is a key mediator contributing to determine the levels of conditioned fear responses. Our results also show that relative to susceptible mice, resistant mice had a much faster recovery from conditioned stimuli-induced cardiovascular and corticosterone responses. Systemic administration of norepinephrine reuptake inhibitor atomoxetine increased c-Fos protein expression in BLA neurons following fear conditioning training and promoted the expression of conditioned fear in resistant mice. Conversely, administration of beta-adrenergic receptor antagonist propranolol reduced fear conditioning training-induced c-Fos protein expression in BLA neurons and reduced conditioned fear responses in susceptible mice. These findings reveal a novel role for the BDNF signaling within the BLA in mediating individual differences in autonomic, neuroendocrine and behavioral reactivity to fear conditioning. CI - Copyright (c) 2014 Elsevier Inc. All rights reserved. FAU - Chou, Dylan AU - Chou D AD - Department of Pharmacology, College of Medicine, National Cheng Kung University, Tainan 701, Taiwan; Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan 701, Taiwan. FAU - Huang, Chiung-Chun AU - Huang CC AD - Department of Pharmacology, College of Medicine, National Cheng Kung University, Tainan 701, Taiwan. FAU - Hsu, Kuei-Sen AU - Hsu KS AD - Department of Pharmacology, College of Medicine, National Cheng Kung University, Tainan 701, Taiwan; Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan 701, Taiwan. Electronic address: richard@mail.ncku.edu.tw. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20140225 PL - United States TA - Exp Neurol JT - Experimental neurology JID - 0370712 RN - 0 (Adrenergic Uptake Inhibitors) RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Propylamines) RN - 0 (Proto-Oncogene Proteins c-fos) RN - 57WVB6I2W0 (Atomoxetine Hydrochloride) SB - IM MH - Acoustic Stimulation MH - Adrenergic Uptake Inhibitors/pharmacology MH - Amygdala/drug effects/*metabolism MH - Animals MH - Association Learning/drug effects/*physiology MH - Atomoxetine Hydrochloride MH - Brain-Derived Neurotrophic Factor/genetics/*metabolism MH - Conditioning, Classical/drug effects/*physiology MH - Fear/drug effects/*physiology MH - Male MH - Mice MH - Mice, Knockout MH - Neurons/drug effects/metabolism MH - Propylamines/pharmacology MH - Proto-Oncogene Proteins c-fos/metabolism OTO - NOTNLM OT - Amygdala OT - Anxiety OT - BDNF OT - Fear conditioning OT - Social defeat stress EDAT- 2014/03/04 06:00 MHDA- 2014/06/10 06:00 CRDT- 2014/03/04 06:00 PHST- 2013/10/08 00:00 [received] PHST- 2014/02/07 00:00 [revised] PHST- 2014/02/11 00:00 [accepted] PHST- 2014/03/04 06:00 [entrez] PHST- 2014/03/04 06:00 [pubmed] PHST- 2014/06/10 06:00 [medline] AID - S0014-4886(14)00061-2 [pii] AID - 10.1016/j.expneurol.2014.02.016 [doi] PST - ppublish SO - Exp Neurol. 2014 May;255:19-29. doi: 10.1016/j.expneurol.2014.02.016. Epub 2014 Feb 25.